DD297997A5 - Proteine, vakzine und nukleinsaeuren - Google Patents

Proteine, vakzine und nukleinsaeuren Download PDF

Info

Publication number
DD297997A5
DD297997A5 DD90341327A DD34132790A DD297997A5 DD 297997 A5 DD297997 A5 DD 297997A5 DD 90341327 A DD90341327 A DD 90341327A DD 34132790 A DD34132790 A DD 34132790A DD 297997 A5 DD297997 A5 DD 297997A5
Authority
DD
German Democratic Republic
Prior art keywords
sequence
protein
dna
nucleic acid
virus
Prior art date
Application number
DD90341327A
Other languages
German (de)
English (en)
Inventor
Heinz
Mandl
Kunz
Dorner
Bodemer
Antoine
Original Assignee
@��@����@��������`������������@��������k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by @��@����@��������`������������@��������k�� filed Critical @��@����@��������`������������@��������k��
Publication of DD297997A5 publication Critical patent/DD297997A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/18—Togaviridae; Flaviviridae
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DD90341327A 1989-06-06 1990-06-05 Proteine, vakzine und nukleinsaeuren DD297997A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP89305708 1989-06-06

Publications (1)

Publication Number Publication Date
DD297997A5 true DD297997A5 (de) 1992-01-30

Family

ID=8202711

Family Applications (1)

Application Number Title Priority Date Filing Date
DD90341327A DD297997A5 (de) 1989-06-06 1990-06-05 Proteine, vakzine und nukleinsaeuren

Country Status (12)

Country Link
EP (1) EP0402116B1 (cs)
JP (1) JPH03151878A (cs)
AT (1) ATE143373T1 (cs)
CA (1) CA2018332A1 (cs)
CZ (1) CZ277921B6 (cs)
DD (1) DD297997A5 (cs)
DE (1) DE69028658T2 (cs)
FI (1) FI902814A7 (cs)
HU (1) HUT54306A (cs)
NO (1) NO902491L (cs)
SK (1) SK277781B6 (cs)
YU (1) YU109590A (cs)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4224402A1 (de) * 1992-07-21 1994-01-27 Schering Ag Neue Pyridin-Derivate mit Leukotrien-B¶4¶-antagonistischer Wirkung
DE4426622C1 (de) * 1994-07-27 1996-02-22 Immuno Ag Infektiöser cDNA-Klon des Tick-Borne Enzephalitis (TBE)-Virus, davon abgeleiteter rekombinanter Impfstoff und Herstellung desselben
FR2794865B1 (fr) 1999-06-09 2003-04-18 Pasteur Institut Methode de detection precoce des flavivirus et ses applications

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3853693D1 (de) * 1987-03-20 1995-06-08 Immuno Ag DNA- und RNA-Moleküle des westlichen Subtyps des FSME-Virus, Polypeptide, die von diesen Molekülen codiert werden, und deren Verwendung.
IL91304A0 (en) * 1988-08-20 1990-03-19 Us Health Recombinant vaccinia virus for prevention of disease caused by flavivirus

Also Published As

Publication number Publication date
NO902491L (no) 1990-12-07
EP0402116A1 (en) 1990-12-12
DE69028658T2 (de) 1997-03-06
HUT54306A (en) 1991-02-28
JPH03151878A (ja) 1991-06-28
YU109590A (sh) 1992-07-20
ATE143373T1 (de) 1996-10-15
FI902814A7 (fi) 1990-12-07
EP0402116B1 (en) 1996-09-25
FI902814A0 (fi) 1990-06-05
SK277781B6 (en) 1995-01-12
CA2018332A1 (en) 1990-12-06
CZ277921B6 (en) 1993-06-16
NO902491D0 (no) 1990-06-05
CS9002806A2 (en) 1991-11-12
DE69028658D1 (de) 1996-10-31
HU903490D0 (en) 1990-10-28

Similar Documents

Publication Publication Date Title
AT408549B (de) Virushältiger impfstoff, rekombinantes virus und verfahren zum exprimieren eines genproduktes
DE69230316T2 (de) Chimäre und/oder wachstumsgehemmte flaviviren
DE69220485T2 (de) Modifizierte pflanzenviren als vektoren
DE68912441T2 (de) Nichtessentielle Geflügelpockenvirus-Regionen.
AT400955B (de) Rekombinantes pockenvirus-wirtsselektionssystem
DE69016956T2 (de) Rekombinantes Truthahn-Herpesvirus und davon abgeleiteter Lebendimpfstoffvektor.
DE3882144T2 (de) Geflügelpocken-virus-promotoren.
DE69535314T2 (de) Modifizierte Pflanzenviren als Vektore für Heterologe Peptide
EP2102345B1 (de) Rsv f-protein und seine verwendung
DE69034075T2 (de) Rekombinantes poxvirus und streptokokken enthaltend ein m-protein
DE69432207T2 (de) Poxvirusvektoren und deren Anwendung als Impstoff gegen Katzenansteckende Peritonitis-Viruskrankheit
DE69231143T2 (de) Spezifische Nukleotidsequenz enthaltender Masernvirusvakzinstamm und Verfahren zu seiner absoluten Identifizierung
DE69627526T2 (de) Rekombinantes pockenvirus der infektiösen peritonitis der katze, dessen zusammensetzungen und methoden zur herstellung und verwendung
DE69929530T2 (de) Attenuierter pferdeherpesvirus
DE69318716T2 (de) Anti-Katze Immundefiziensvirus (FIV) Impfstoffe
DE69012386T3 (de) Impfstoff und Diagnostikum für den Schweine-Cholera-Virus.
DE3813093A1 (de) Rekombinantes plasmid, verfahren zum herstellen eines rekombinanten avipoxvirus, rekombinantes avipoxvirus und dessen verwendung
DE69332393T2 (de) Rekombinanter Katzen-Herpesvirus-Impfstoff
EP0284791B1 (de) DNA- und RNA-Moleküle des westlichen Subtyps des FSME-Virus, Polypeptide, die von diesen Molekülen codiert werden, und deren Verwendung
DE3752182T2 (de) Abgeschwächte herpesviren, herpesviren, die eine für aminosäuresequenzen kodierende fremd-dns enthalten, sowie impfstoffe, die diese enthalten
DE3855076T2 (de) Vakzin gegen Rinderpestvirus unter Benutzung von rekombinantem Vacciniavirus
DE69332480T2 (de) Impfstoff-vektoren von rekombinantem katzen-herpesvirus
DE69028658T2 (de) Proteine, Vakzine und Nucleinsäuren
DE69031735T2 (de) Erzeugung von hybrid-genen und proteinen durch rekombination mittels viren
WO1992011370A2 (de) Von proteinen des hepatitis c-virus abgeleitete polypeptide und deren verwendung

Legal Events

Date Code Title Description
RPV Change in the person, the name or the address of the representative (searches according to art. 11 and 12 extension act)
ENJ Ceased due to non-payment of renewal fee